These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 20940053

  • 1. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
    Comai S, Cavalletto L, Chemello L, Bernardinello E, Ragazzi E, Costa CV, Bertazzo A.
    Pharmacol Res; 2011 Jan; 63(1):85-92. PubMed ID: 20940053
    [Abstract] [Full Text] [Related]

  • 2. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
    Vignau J, Costisella O, Canva V, Imbenotte M, Duhamel A, Lhermitte M.
    Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
    [Abstract] [Full Text] [Related]

  • 3. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
    Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpé S, Maes M.
    Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
    [Abstract] [Full Text] [Related]

  • 4. HCV patients, psychopathology and tryptophan metabolism: analysis of the effects of pegylated interferon plus ribavirin treatment.
    Zignego AL, Cozzi A, Carpenedo R, Giannini C, Rosselli M, Biagioli T, Aldinucci A, Laffi G, Moroni F.
    Dig Liver Dis; 2007 Sep; 39 Suppl 1():S107-11. PubMed ID: 17936210
    [Abstract] [Full Text] [Related]

  • 5. Alterations in the metabolism of tryptophan in patients with chronic hepatitis C six months after pegylated interferon-α 2a treatment.
    Pawlowski T, Malyszczak K, Inglot M, Zalewska M, Radkowski M, Laskus T, Pawlak D.
    Psychoneuroendocrinology; 2018 Nov; 97():1-7. PubMed ID: 29990677
    [Abstract] [Full Text] [Related]

  • 6. Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.
    Berenguer J, González-García J, López-Aldeguer J, Von-Wichmann MA, Quereda C, Hernando A, Sanz J, Tural C, Ortega E, Mallolas J, Santos I, Miralles P, Montes ML, Bellón JM, Esteban H, GESIDA HIV/HCV cohort.
    J Antimicrob Chemother; 2009 Jun; 63(6):1256-63. PubMed ID: 19363085
    [Abstract] [Full Text] [Related]

  • 7. Pegylated alpha-interferon-2a plus ribavirin compared with pegylated alpha-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: prospective, non-randomized study.
    Escudero A, Rodríguez F, Serra MA, Del Olmo JA, Montes F, Rodrigo JM.
    J Gastroenterol Hepatol; 2008 Jun; 23(6):861-6. PubMed ID: 18422960
    [Abstract] [Full Text] [Related]

  • 8. Serum transaminase elevations during pegylated interferon treatment of chronic HCV hepatitis probably induced by polyethylene glycol.
    Caroleo B, Gallelli L, Staltari O, De Sarro G, Guadagnino V.
    Intervirology; 2008 Jun; 51(6):407-9. PubMed ID: 19258719
    [Abstract] [Full Text] [Related]

  • 9. The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
    Pawlowski T, Pawlak D, Inglot M, Zalewska M, Marciniak D, Bugajska J, Janocha-Litwin J, Malyszczak K.
    J Psychiatry Neurosci; 2021 Jan 18; 46(1):E166-E175. PubMed ID: 33464780
    [Abstract] [Full Text] [Related]

  • 10. The response to pegylated interferon alpha 2a in haemodialysis patients with hepatitis C virus infection.
    Akhan SC, Kalender B, Ruzgar M.
    Infection; 2008 Aug 18; 36(4):341-4. PubMed ID: 18629437
    [Abstract] [Full Text] [Related]

  • 11. DEPRESSIVE EPISODE INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN.
    Vabo IL, Ferreira LE, Pace FH.
    Arq Gastroenterol; 2016 Aug 18; 53(1):20-4. PubMed ID: 27281500
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV).
    Pawlowski T, Malyszczak K, Pawlak D, Inglot M, Zalewska M, Grzywacz A, Radkowski M, Laskus T, Janocha-Litwin J, Frydecka D.
    Cells; 2023 Mar 22; 12(6):. PubMed ID: 36980311
    [Abstract] [Full Text] [Related]

  • 15. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM, Huang PT, Tsai MH, Lin LF, Liu CC, Ho KS, Siauw CP, Chao PL, Tung JN.
    J Gastroenterol Hepatol; 2007 May 22; 22(5):669-75. PubMed ID: 17444854
    [Abstract] [Full Text] [Related]

  • 16. Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection.
    Mahajan S, Avasthi A, Grover S, Chawla YK.
    J Psychosom Res; 2014 Aug 22; 77(2):109-15. PubMed ID: 25077851
    [Abstract] [Full Text] [Related]

  • 17. Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy).
    Halfon P, Pérusat S, Bourlière M, Bronowicki JP, Trimoulet P, Benhamou Y, Leroy V, Marcellin P, Foucher J, Penaranda G, Chêne G, Couzigou P, ANRS HC16 GAMMATRI Study Group.
    J Med Virol; 2010 Dec 22; 82(12):2027-31. PubMed ID: 20981789
    [Abstract] [Full Text] [Related]

  • 18. Does the antiviral therapy of patients with chronic hepatitis exert nephrotoxic effects?
    Gluhovschi C, Gadalean F, Kaycsa A, Curescu M, Sporea I, Gluhovschi G, Petrica L, Velciov S, Bozdog G, Bob F, Vernic C, Cioca D.
    Immunopharmacol Immunotoxicol; 2011 Dec 22; 33(4):744-50. PubMed ID: 21320001
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the Safety Profiles of Pegylated Interferon α-2a and α-2b Administered in Combination with Ribavirin for Chronic Hepatitis C Infection: A Real-World Retrospective Cohort Study.
    Ide K, Sato I, Imai T, Hawke P, Yamada H, Kawasaki Y, Masaki N.
    Biol Pharm Bull; 2016 Dec 01; 39(12):2060-2065. PubMed ID: 27645378
    [Abstract] [Full Text] [Related]

  • 20. Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients.
    Fumaz CR, Muñoz-Moreno JA, Ballesteros AL, Paredes R, Ferrer MJ, Salas A, Fuster D, Masmitjà E, Pérez-Alvarez N, Gómez G, Tural C, Clotet B.
    AIDS Care; 2007 Jan 01; 19(1):138-45. PubMed ID: 17129869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.